Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 7 points (0.0%) at 17,094 as of Thursday, July 24, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,609 issues advancing vs. 1,334 declining with 169 unchanged. The Health Services industry currently sits up 0.2% versus the S&P 500, which is up 0.1%. Top gainers within the industry include Chemed ( CHE), up 4.8%, Health Net ( HNT), up 4.3%, Cooper Companies ( COO), up 1.8%, Universal Health Services ( UHS), up 1.2% and Fresenius Medical Care AG & Co. KGaA ( FMS), up 0.8%. TheStreet would like to highlight 3 stocks pushing the industry lower today: 3. Invacare ( IVC) is one of the companies pushing the Health Services industry lower today. As of noon trading, Invacare is down $2.60 (-14.8%) to $14.98 on heavy volume. Thus far, 439,928 shares of Invacare exchanged hands as compared to its average daily volume of 179,800 shares. The stock has ranged in price between $14.88-$17.33 after having opened the day at $17.20 as compared to the previous trading day's close of $17.58. Invacare Corporation designs, manufactures, and distributes medical equipment and supplies worldwide. The company operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and Asia/Pacific. Invacare has a market cap of $553.6 million and is part of the health care sector. Shares are down 24.3% year-to-date as of the close of trading on Wednesday. Currently there are no analysts that rate Invacare a buy, no analysts rate it a sell, and 1 rates it a hold. TheStreet Ratings rates Invacare as a hold. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full Invacare Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.